NICE propose to charge £142,000 to conduct single technology appraisals from May 2017.
Read more HERE
NICE propose to charge £142,000 to conduct single technology appraisals from May 2017.
Read more HERE
UK, Canada and United States join forces to streamline process and increase transparency for confide...
Read moreOur client had concerns as to whether the clinical end-points in their phase III trial were relevant...
Read moreBe the first to receive exclusive content on the latest from the pharmaceutical and market access sector.
Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.
Get in touch